Search

Your search keyword '"Altman, Peter"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Altman, Peter" Remove constraint Author: "Altman, Peter"
119 results on '"Altman, Peter"'

Search Results

1. CryptoLink - September 2024 Updates

2. CryptoLink - August 2024 Updates

3. Supreme Court Narrows Federal Bribery Statute That Applies To State And Local Officials

4. CryptoLink - February 2024 Updates

5. FinCEN Proposes New Rule To Expand Anti-Money Laundering Requirements For Investment Advisers

6. SEC Fines 16 Firms More Than $81 Million For Off-Channel Communications

7. CryptoLink - June 2023

8. SEC Recordkeeping V. Privacy: Recent Opinion Stirs Debate

9. Landmark SEC And DOJ Insider Trading Cases Signal Increased Scrutiny Of Rule 10b5-1 Plans

10. CryptoLink

11. A Fractured Framework: Regulatory Actions Against Mango Token Trader Highlight Complexities Of Crypto Enforcement

12. Blaszczak II: 2nd Circuit Reverses Course And Overturns Insider Trading Convictions

13. DOJ Criminal Division Announces New Round Of Revisions To Corporate Enforcement Policy

14. CryptoLink - December 2022

15. Deputy AG Announces Significant Changes To DOJ Policies Regarding Corporate Investigations

16. Second Circuit Confirms The Scope Of Scheme Liability Under Rule 10b-5

17. SEC Division Of Examinations (Finally) Speaks On Alternative Data

18. Regulatory Investigations And Enforcement Trends In 2022

19. Increasing Government Enforcement In Insider Trading Of Commodities

20. SEC Cyber Enforcement Actions - Lessons For Private Fund Managers

21. ENVIRONMENTALISTS, LABOR GROUPS SLAM EPA'S NEWEST CAM RULE

22. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

23. Cross Trades And Principal Transactions - New SEC Guidance For Private Fund Managers

24. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort

26. Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial

27. National Defense Authorization Act Boosts SEC's Disgorgement Authority And Ability To Seek Other Equitable Relief

29. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

31. SEC Warns Registrants Of Risks Associated With Dangerous Malware

34. Strip extensiometry for comparison of the mechanical response of bovine, rabbit, and human corneas

35. SEC OCIE Issues Guidance On Advisors' And Broker-Dealers' Cloud-Based And Other Network Storage Of Customer Data

38. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post–myocardial infarction heart failure: Trial rationale and study design

39. Government Agencies Face Uncertainty After Supreme Court Rules That SEC ALJs Must Be Appointed

41. 18 Questions: Life and the Universe

42. Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?

45. DOES TRANSENDOCARDIAL INJECTION OF MESENCHYMAL STEM CELLS IMPROVE MYOCARDIAL FUNCTION LOCALLY, OR GLOBALLY: AN ANALYSIS FROM THE POSEIDON TRIAL

48. PRELIMINARY RESULTS FROM THE TRANSENDOCARDIAL INJECTIONS OF AUTOLOGOUS WHOLE BONE MARROW AND MESENCHYMAL STEM CELLS IN ISCHEMIC HEART FAILURE (TAC-HFT) TRIAL

49. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy

50. Three-year follow-up in an open-label, pilot study of transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter

Catalog

Books, media, physical & digital resources